Neuberger Berman Group
RNAM

Neuberger Berman Group’s Avidity Biosciences RNAM Stock Holding History

Neuberger Berman Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-622,439
Closed -$44.9M – 2236
2025
Q4 		$44.9M Buy
622,439
+461,004
+286% +$29.8M 0.03% 491
2025
Q3 		$7.03M Buy
+161,435
New +$6.53M 0.01% 886
2024
Q4 		– Sell
-4,919
Closed -$226K – 2000
2024
Q3 		$226K Buy
+4,919
New +$213K ﹤0.01% 1767

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Neuberger Berman Group's RNAM Position: Q1 2026 in Review

Neuberger Berman Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 622,439 shares — an estimated $44.9M sold.

Neuberger Berman Group first reported a position in RNAM in Q3 2024 and held it in 3 quarters. The position peaked at $44.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Neuberger Berman Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 622,439 Avidity Biosciences shares in Q1 2026, an estimated $44.9M.
  • Neuberger Berman Group first reported a position in Avidity Biosciences in Q3 2024 and held it in 3 quarters.
  • Neuberger Berman Group's Avidity Biosciences position peaked at $44.9M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.